Skip to content

Floctafenine

NERVOUS SYSTEM

Also known as: diralgan, floctafenin, idarac, novodolan

ATC N02BG04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Floctafenine is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including PTGS1 and PTGS2. Recorded indications include Acute pain.

  • Molecular targets: PTGS1 and PTGS2 (2 listed in DrugCentral).
  • Indications: Acute pain.
  • ATC code: N02BG04 (Other analgesics and antipyretics).
  • Molecular formula: C20H17F3N2O4; molecular weight 406.36 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Acute pain

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Prostaglandin G/H synthase 1PTGS1inhibitorIC50 6.27
Prostaglandin G/H synthase 2PTGS2inhibitorIC50 5.96

ATC classification

ATC codeTherapeutic hierarchy
N02BG04NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Other analgesics and antipyretics

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Floctafenine is on its molecule page.

Molecular formulaC20H17F3N2O4
Molecular weight406.36 g/mol
CAS number23779-99-9
InChIKeyAPQPGQGAWABJLN-UHFFFAOYSA-N
PubChem CID3360
OCC(O)COC(=O)C1=C(NC2=CC=NC3=C(C=CC=C23)C(F)(F)F)C=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Floctafenine used for?

DrugCentral lists the following indications for Floctafenine: Acute pain.

How does Floctafenine work?

Its molecular targets in DrugCentral include PTGS1 (inhibitor) and PTGS2 (inhibitor).

What is the chemical formula of Floctafenine?

Floctafenine has the molecular formula C20H17F3N2O4 and a molecular weight of 406.36 g/mol.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets2
Indications1
FormulaC20H17F3N2O4
DrugCentral ID1178
Interactive profile